Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.

Trombetti, Andrea; Al-Daghri, Nasser; Brandi, Maria Luisa; Cannata-Andía, Jorge B; Cavalier, Etienne; Chandran, Manju; Chaussain, Catherine; Cipullo, Lucia; Cooper, Cyrus; Haffner, Dieter; Harvengt, Pol; Harvey, Nicholas C; Javaid, Muhammad Kassim; Jiwa, Famida; Kanis, John A; Laslop, Andrea; Laurent, Michaël R; Linglart, Agnès; Marques, Andréa; Mindler, Gabriel T; Minisola, Salvatore; Yerro, María Concepción Prieto; Rosa, Mario Miguel; Seefried, Lothar; Vlaskovska, Mila; Zanchetta, María Belén; Rizzoli, René

Trombetti, Andrea; Al-Daghri, Nasser; Brandi, Maria Luisa; Cannata-Andía, Jorge B; Cavalier, Etienne; Chandran, Manju; Chaussain, Catherine; Cipullo, Lucia; Cooper, Cyrus; Haffner, Dieter; Harvengt, Pol; Harvey, Nicholas C; Javaid, Muhammad Kassim; Jiwa, Famida; Kanis, John A; Laslop, Andrea; Laurent, Michaël R; Linglart, Agnès; Marques, Andréa; Mindler, Gabriel T; Minisola, Salvatore; Yerro, María Concepción Prieto; Rosa, Mario Miguel; Seefried, Lothar; Vlaskovska, Mila; Zanchetta, María Belén; Rizzoli, René.

Affiliation

Trombetti A; Division of Bone Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Al-Daghri N; Division of Geriatrics, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Brandi ML; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Cannata-Andía JB; F.I.R.M.O. Foundation, University of Florence, Florence, Italy.
Cavalier E; Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Chandran M; Universidad de Oviedo, Oviedo, Spain.
Chaussain C; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Cipullo L; Retic REDinREN-RICORS, 2040-ISCIII, Madrid, Spain.
Cooper C; Department of Clinical Chemistry, University of Liege, CHU de Liège, Liège, Belgium.
Haffner D; Complicated Metabolic Bone Disorders Clinic, Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
Harvengt P; Université de Paris, Institut des maladies musculo-squelettiques, URP2496, UFR Odontologie, Montrouge, France.
Harvey NC; AP-HP, FHU DDS-Net, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphore, Service médecine bucco-dentaire, Hôpital Bretonneau, GH Paris Nord Université de Paris, Paris, France.
Javaid MK; Patient representative with XLH, Geneva, Switzerland.
Jiwa F; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
Kanis JA; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Laslop A; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Laurent MR; Department of Paediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Linglart A; XLH Belgium, Belgian association of patients with XLH (a member of the International XLH Alliance), Waterloo, Belgium.
Marques A; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
Mindler GT; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Minisola S; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Yerro MCP; Chair of the Committee of Patients Societies at the International Osteoporosis Foundation, Osteoporosis Canada, Toronto, Canada.
Rosa MM; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Seefried L; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Vlaskovska M; Scientific Office, Federal Office for Safety in Health Care, Vienna, Austria.
Zanchetta MB; Centre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium.
Rizzoli R; Paris-Saclay University, INSERM U1185, Le Kremlin-Bicêtre, France.

Nat Rev Endocrinol ; 18(6): 366-384, 2022 06.

Article de En | MEDLINE | ID: mdl-35484227

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Arthrose / Syndrome cachectique / Rachitisme hypophosphatémique familial / Facteur-23 de croissance des fibroblastes Type d'étude: Diagnostic_studies Aspects: Patient_preference Limites: Adult / Animals / Humans Langue: En Journal: Nat Rev Endocrinol Sujet du journal: ENDOCRINOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google